Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Panella

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Breast Cancer|July 5, 2011
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancerAdam Brufsky, Karen Hoelzer, Thaddeus Beck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) StudyGuilherme Rabinowits, Soo J Park, Nikhil I Khushalani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) StudyGuilherme Rabinowits, Soo J Park, Nikhil I Khushalani, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Breast Cancer|July 5, 2011
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancerAdam Brufsky, Karen Hoelzer, Thaddeus Beck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) StudyGuilherme Rabinowits, Soo J Park, Nikhil I Khushalani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
HSR26-247: Real-World Quality of Life in Patients Treated With Cemiplimab for Advanced Cutaneous Squamous Cell Carcinoma: Results of CemiplimAb Survivorship Epidemiology (CASE) StudyGuilherme Rabinowits, Soo J Park, Nikhil I Khushalani, et al.
Pageof 2